UroGen Pharma, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$7.3M
Doctors Paid
7,252
Transactions
25,229
2024 Total
$1.7M
Payment Breakdown by Category
Research$1.7M (22.9%)
Food & Beverage$763,178 (10.4%)
Consulting$649,663 (8.9%)
Travel$157,085 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3.0M | 76 | 41.4% |
| Unspecified | $1.7M | 778 | 22.9% |
| Honoraria | $980,904 | 293 | 13.4% |
| Food and Beverage | $763,178 | 23,056 | 10.4% |
| Consulting Fee | $649,663 | 235 | 8.9% |
| Travel and Lodging | $157,085 | 365 | 2.1% |
| Space rental or facility fees (teaching hospital only) | $34,400 | 11 | 0.5% |
| Gift | $30,250 | 74 | 0.4% |
| Education | $4,327 | 341 | 0.1% |
Payments by Type
General
$5.7M
24,451 transactions
Research
$1.7M
778 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| UROGEN BL-006 | $472,488 | 0 | 188 |
| UROGEN PHARMA BL007 | $156,290 | 0 | 91 |
| UTRACT JELMYTO REGISTRY - A REGISTRY OF PATIENTS WITH UPPER TRACT UROTHELIAL CANCER (UTUC) TREATED WITH JELMYTO (UTRACT) | $104,235 | 3 | 19 |
| UTRACT JELMYTO REGISTRY A REGISTRY OF PATIENTS WITH UPPER TRACT UROTHELIAL CANCER UTUC TREATED WITH JELMYTO UTRACT | $96,448 | 0 | 7 |
| QUALITY OF CARE AND COST-ANALYSIS IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA | $89,568 | 0 | 2 |
| UROGEN BL006 | $56,875 | 0 | 320 |
| BL007 - A ROLLOVER STUDY TO FOLLOW THE LONG-TERM OUTCOMES OF PATIENTS FROM STUDY UT001 (FORMERLY TC-UT-03) AND STUDY TC-BC-12 | $33,087 | 0 | 56 |
| OLYMPUS | $19,214 | 0 | 36 |
| UROGEN BL010 | $13,079 | 0 | 22 |
| OLYMPUS FINAL MANUSCRIPT | $9,152 | 26 | 26 |
| BL010 | $1,306 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Seth Lerner, Md, MD | Urology | Houston, TX | $7,200 | $0 |
| Dr. Amy Luckenbaugh, Md, MD | Student in an Organized Health Care Education/Training Program | Nashville, TN | $6,753 | $0 |
| Ashish Kamat, M.d, M.D | Urology | Houston, TX | $6,587 | $0 |
| Brant Inman, M.d, M.D | Urology | Durham, NC | $6,458 | $0 |
| Dr. Scott Sellinger, Md, MD | Urology | Tallahassee, FL | $6,442 | $0 |
| Dr. Kent Mouw, M.d., Ph.d, M.D., PH.D | Internal Medicine | Boston, MA | $6,400 | $0 |
| Colin Dinney, M.d, M.D | Urology | Houston, TX | $6,400 | $0 |
| Petros Grivas, M.d, M.D | Medical Oncology | Seattle, WA | $6,400 | $0 |
| Bryan Mehlhaff, Md, MD | Urology | Springfield, OR | $6,386 | $0 |
| Charles Peyton | Urology | Birmingham, AL | $6,181 | $0 |
| Dr. Vincent Bivins, Md, MD | Urology | Homewood, AL | $5,983 | $0 |
| Dr. Evan Goldfischer, Md, MD | Urology | Poughkeepsie, NY | $5,324 | $0 |
| Paul Eber, M.d, M.D | Urology | Germantown, TN | $5,206 | $0 |
| Dr. Abhishek Srivastava, M.d, M.D | Urology | Myrtle Beach, SC | $5,059 | $0 |
| Seth Lerner, M.d, M.D | Urology | White Plains, NY | $4,938 | $0 |
| Janet Kukreja, M.d, M.D | Urology | Aurora, CO | $4,800 | $0 |
| Roger Li, M.d, M.D | Student in an Organized Health Care Education/Training Program | Loma Linda, CA | $4,800 | $0 |
| Kristen Scarpato, Md, MD | Urology | Nashville, TN | $4,648 | $0 |
| Cheryl Lee, Md, MD | Urology | Columbus, OH | $4,611 | $0 |
| Jay Raman, M.d, M.D | Urology | Hershey, PA | $4,522 | $0 |
| Wade Sexton, Md, MD | Urology | Tampa, FL | $4,397 | $0 |
| Dr. David Ellis, M.d, M.D | Urology | Rosemont, PA | $4,383 | $0 |
| Dr. Aditya Bagrodia, Md, MD | Urology | San Diego, CA | $4,364 | $0 |
| Harrison Abrahams, Md, MD | Urology | Arlington, TX | $4,264 | $0 |
| Peter Clark, Md, MD | Urology | Charlotte, NC | $4,245 | $0 |
About UroGen Pharma, Inc.
UroGen Pharma, Inc. has made $7.3M in payments to 7,252 healthcare providers, recorded across 25,229 transactions in the CMS Open Payments database. In 2024, the company paid $1.7M. The top product by payment volume is JELMYTO ($2.3M).
Payments were distributed across 99 medical specialties. The top specialty by payment amount is Urology ($4.0M to 4,184 doctors).
Payment categories include: Food & Beverage ($763,178), Consulting ($649,663), Research ($1.7M), Travel & Lodging ($157,085).
UroGen Pharma, Inc. is associated with 1 products in the CMS Open Payments database.